Manchester Capital Management LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1393389 MANCHESTER, VT

Position in ARWR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$163

-$33,602 QoQ

Shares Held

-99.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#492

of 497 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Manchester Capital Management LLC holds $805,024 across 28 Biotechnology names. ARWR ranks #26 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REPL	Replimune Group, Inc.	25,675	$284,222
2	VRTX	Vertex Pharmaceuticals Inc / Ma	391	$194,221
3	INSM	INSMED Inc	1,033	$110,138
4	RPRX	Royalty Pharma plc	694	$38,912
5	REGN	Regeneron Pharmaceuticals, Inc.	47	$29,306
6	ABVX	Abivax S.A.	200	$26,652
7	ALNY	Alnylam Pharmaceuticals, Inc.	83	$24,985
8	MRNA	Moderna, Inc.	321	$22,479

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$163	2	-99.8%	Shares	Sole	2026-08-13
2025-09-30	$33,765	979	0.0%	Shares	Sole	2025-11-14
2025-06-30	$15,468	979	+123.0%	Shares	Sole	2025-08-12
2025-03-31	$5,592	439	+1729.2%	Shares	Sole	2025-05-09
2023-09-30	$644	24	-11.1%	Shares	Sole	2023-11-09
2023-06-30	$962	27	0.0%	Shares	Sole	2023-08-14
2023-03-31	$685	27	0.0%	Shares	Sole	2023-05-09
2022-12-31	$1,095	27	0.0%	Shares	Sole	2023-02-09
2022-09-30	$892	27	0.0%	Shares	Sole	2022-11-08
2022-06-30	$950	27	0.0%	Shares	Sole	2022-08-10
2022-03-31	$1,241	27	-89.4%	Shares	Sole	2022-05-09
2021-12-31	$16,840	254	0.0%	Shares	Sole	2022-02-10
2021-09-30	$15,857	254	+840.7%	Shares	Sole	2021-11-12
2021-06-30	$2,236	27	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.